Mizuho lowers Humana stock price target to $310 on Medicare Advantage concerns
NegativeFinancial Markets

Mizuho lowers Humana stock price target to $310 on Medicare Advantage concerns
Mizuho has lowered its stock price target for Humana to $310 due to concerns surrounding Medicare Advantage plans. This adjustment reflects growing apprehension about the sustainability and profitability of these plans, which are crucial for Humana's business model. Investors should pay attention to these developments as they could impact Humana's market performance and overall healthcare landscape.
— via World Pulse Now AI Editorial System




